A Phase Ii Study Of Efficacy And Safety Of Rc48-Adc In Patients With Locally Advanced Or Metastatic Her2-Overexpressing Gastric Or Gastroesophageal Junction Cancers.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要